Cargando…
Rivaroxaban Treatment for Warfarin-Refractory Thrombosis in a Patient with Hereditary Protein S Deficiency
Protein S (PS) deficiency, an autosomal dominant hereditary thrombophilia, is more prevalent in East Asian populations than in Caucasians. PS-deficient patients have historically been administered a heparin product followed by warfarin for the treatment and secondary prevention of venous thromboembo...
Autores principales: | Ameku, Koken, Higa, Mariko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5828494/ https://www.ncbi.nlm.nih.gov/pubmed/29607227 http://dx.doi.org/10.1155/2018/5217301 |
Ejemplares similares
-
Complete Remission of Multiple Brain Metastases in a Patient with EGFR-Mutated Non-Small-Cell Lung Cancer Treated with First-Line Osimertinib without Radiotherapy
por: Ameku, Koken, et al.
Publicado: (2020) -
Stanford type IV venous collateral blood flow following complete chronic occlusion of the superior vena cava in a patient with lung cancer
por: Ameku, Koken, et al.
Publicado: (2020) -
The Role of Warfarin and Rivaroxaban in the Treatment of Cerebral Venous Thrombosis
por: Fayyaz, Muniba, et al.
Publicado: (2019) -
Successful use of rivaroxaban in postoperative deep vein thrombosis of the lower limb following instability with warfarin: a case report
por: Schiavoni, Mario, et al.
Publicado: (2016) -
Resolution of Extensive Coronary Thrombosis under Rivaroxaban
Treatment
por: Yuksel, Murat, et al.
Publicado: (2015)